Swiss Re’s Boston Scientific BSX Stock Holding History

Swiss Re’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$117K	Buy	2,748 +2,475	+907%	+$134K	0.01%	208
2026 Q1	$17.1K	Hold	273	–	–	0.1%	147
2025 Q4	$26K	Buy	+273	New	+$26.8K	﹤0.01%	92

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swiss Re's BSX Position: Q2 2026 in Review

Swiss Re increased its Boston Scientific (BSX) stake by 907% in Q2 2026, buying an estimated $134K and bringing the position to 2,748 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #208.

Swiss Re first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Swiss Re held 2,748 shares of Boston Scientific worth $117K as of Q2 2026.
Swiss Re bought 2,475 Boston Scientific shares in Q2 2026, an estimated $134K.
Boston Scientific made up 0.01% of Swiss Re's portfolio in Q2 2026, its #208 holding.
Swiss Re first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.